Literature DB >> 32042828

The contributor roles for randomized controlled trials and the proposal for a novel CRediT-RCT.

Zhongheng Zhang1, Stephen D Wang2, Grace S Li2, Guilan Kong3,4, Hongqiu Gu5, Fernando Alfonso6.   

Abstract

BACKGROUND: The past decade has witnessed a rapid increase in the number of contributors per article, which has made explicitly defining the roles of each contributor even more challenging. The Contributor Roles Taxonomy (CRediT) was developed to explicitly define author roles, but there is a lack of empirical data on how CRediT is used in clinical trials. This study aimed to provide empirical data on the use of CRediT in randomized controlled trials (RCTs) and discuss some limitations of CRediT. A new taxonomy (CRediT-RCT) is proposed to explicitly define the author roles in RCTs.
METHODS: The electronic database of PubMed was searched from July 2017 to October 2019 to identify component trials with a randomized controlled design. Publications from the Public Library of Science (PLoS) were included because they embed the CRediT roles within the authors' metadata rather than solely as a separate paragraph of text.
RESULTS: A total of 446 articles involving 4,185 authors were included in the study. Most authors participated in the study's conceptualization (44.9%) and investigation (48.8%), but only a fraction of the authors participated in software management (7.4%). Many CRediT roles were correlated with each other: the strongest correlation was the one between funding acquisition and conceptualization (correlation metric =0.39), followed by the one between conceptualization and methodology (0.37). The authors who acquired funding (OR: 2.06; 95% CI: 1.54-2.76; P<0.001), did project administration (OR: 1.54; 95% CI: 1.17-2.03; P=0.002), performed supervision (OR: 2. 60; 95% CI: 1.93-3.52; P<0.001), wrote the original draft (OR: 4.83; 95% CI: 3.54-6.60; P<0.001), or were the first author (OR: 7.85; 95% CI: 5.71-10.87; P<0.001), were more likely to be the corresponding author. Also, while the original draft writing was significantly associated with the designation of the first author (OR: 37.49; 95% CI: 25.29-57.57; P<0.001), the first author did not perform review and editing (OR: 0.55; 95% CI: 0.40-0.75; P<0.001), supervision (OR: 0.49; 95% CI: 0.36-0.67; P<0.001), or resource management (OR: 0.71; 95% CI: 0.50-1.00; P=0.053). We further propose a novel Contributor Roles Taxonomy for Randomized Controlled Trials (CRediT-RCT) which includes 10 roles.
CONCLUSIONS: The present study provides empirical data on the use of CRediT for RCTs, and some limitations of the taxonomy are discussed. We further propose a new CRediT-RCT which includes 10 roles. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Contribution; authorship; contributor roles; randomized controlled trial; taxonomy

Year:  2019        PMID: 32042828      PMCID: PMC6989869          DOI: 10.21037/atm.2019.12.96

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  13 in total

1.  When authorship fails. A proposal to make contributors accountable.

Authors:  D Rennie; V Yank; L Emanuel
Journal:  JAMA       Date:  1997-08-20       Impact factor: 56.272

Review 2.  Authorship: from credit to accountability. Reflections from the Editors' Network.

Authors:  Fernando Alfonso; Parounak Zelveian; Jean-Jacques Monsuez; Michael Aschermann; Michael Böhm; Alfonso Buendia Hernandez; Tzung-Dau Wang; Ariel Cohen; Sebija Izetbegovic; Anton Doubell; Dario Echeverri; Nuray Enç; Ignacio Ferreira-González; Anetta Undas; Ulrike Fortmüller; Plamen Gatzov; Carmen Ginghina; Lino Goncalves; Faouzi Addad; Mahmoud Hassanein; Gerd Heusch; Kurt Huber; Robert Hatala; Mario Ivanusa; Chu-Pak Lau; Germanas Marinskis; Livio Dei Cas; Carlos Eduardo Rochitte; Kjell Nikus; Eckart Fleck; Luc Pierard; Slobodan Obradović; María Del Pilar Aguilar Passano; Yangsoo Jang; Olaf Rødevand; Mikael Sander; Evgeny Shlyakhto; Çetin Erol; Dimitris Tousoulis; Dilek Ural; Jan J Piek; Albert Varga; Andreas J Flammer; François Mach; Alban Dibra; Faiq Guliyev; Alexander Mrochek; Mamanti Rogava; Ismael Guzman Melgar; Giuseppe Di Pasquale; Kanat Kabdrakhmanov; Laila Haddour; Zlatko Fras; Claes Held; Valentyn Shumakov
Journal:  Basic Res Cardiol       Date:  2019-04-08       Impact factor: 17.165

3.  Authorship: Who's on first?

Authors:  Amber Dance
Journal:  Nature       Date:  2012-09-27       Impact factor: 49.962

4.  Perceptions of authors' contributions are influenced by both byline order and designation of corresponding author.

Authors:  Mohit Bhandari; Gordon H Guyatt; Abhaya V Kulkarni; Philip J Devereaux; Pamela Leece; Sohail Bajammal; Diane Heels-Ansdell; Jason W Busse
Journal:  J Clin Epidemiol       Date:  2014-06-26       Impact factor: 6.437

5.  Site Principal Investigators in Multicenter Clinical Trials: Appropriately Recognizing Key Contributors.

Authors:  Robert J Mentz; Eric D Peterson
Journal:  Circulation       Date:  2017-03-28       Impact factor: 29.690

6.  Addressing Authorship Issues Prospectively: A Heuristic Approach.

Authors:  Laura Weiss Roberts
Journal:  Acad Med       Date:  2017-02       Impact factor: 6.893

7.  Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications.

Authors:  Angela Stocks; Donna Simcoe; Dikran Toroser; Lisa DeTora
Journal:  Curr Med Res Opin       Date:  2018-04-16       Impact factor: 2.580

8.  Authorship Considerations for Publishing in Pharmacy Education Journals.

Authors:  Lana M Minshew; Jacqueline E McLaughlin
Journal:  Am J Pharm Educ       Date:  2019-08       Impact factor: 2.047

9.  Endorsement of the Contributor Roles Taxonomy for the clarification of authorship.

Authors:  Tae-Il Kim
Journal:  J Periodontal Implant Sci       Date:  2017-02-28       Impact factor: 2.614

10.  Transparency in authors' contributions and responsibilities to promote integrity in scientific publication.

Authors:  Marcia K McNutt; Monica Bradford; Jeffrey M Drazen; Brooks Hanson; Bob Howard; Kathleen Hall Jamieson; Véronique Kiermer; Emilie Marcus; Barbara Kline Pope; Randy Schekman; Sowmya Swaminathan; Peter J Stang; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.